 |
|
Brisbane teens receive first cancer vaccine shots
August 29, 2006UQ Professor Ian Frazer administered the first shots of the cervical cancer vaccine Gardasil in Queensland this afternoon at the Princess Alexandra Hospital.
Rochedale sisters Emma and Rachel McMillan were the first teenage recipients of the Australian-made vaccine which Professor Frazer and his late research partner Dr Jian Zhou helped create.
The vaccine prevents four of dozens of strains of the human papillomavirus (HPV) which cause genital warts and cervical cancer.
The prescription-only vaccine is distributed in Australia and New Zealand by Melbourne based pharmaceutical manufacturer CSL and distributed worldwide by US drugmaker Merck & Co.
It sells for $465 for a three-dose shot but there are plans to have it considered for subsidy under the Pharmaceutical Benefits Scheme and eventually added to the national vaccination program for girls aged 12.
Professor Frazer, the immunologist named 2006 Australian of the Year for his team's work on the vaccine, is the Director of UQ's Centre for Immunology and Cancer Research.
Queensland Treasurer Anna Bligh announced a new Senior Smart State Fellowship at the vaccine launch in honour of Dr Zhou.
Ms Bligh said the three-year, $450,000 Jian Zhou Fellowship would be offered to a Queenslander to advance research and development in immunology and cancer research.
The State Government will contribute $100,000 a year for three years, matched by a $50,000-a-year commitment from CSL.
Professor Zhou's son Andreas, a 20-year-old industrial design student, said he was proud of his father's legacy.
"We're really happy that the vaccine has come through with 100 percent on the test trials but also really sad because my father can't be here with us today," Mr Zhou said.
"We're happy it's finally out there and people can start getting vaccinated."
Gardasil has been approved for use in girls and women aged nine to 26 in Australia and the US.
Cervical cancer kills about 270,000 women worldwide each year.
HPV causes abnormal cells or tissue growth on the feet, hands, vocal cords, mouth and genitals.
About 60 types of HPV have been identified so far with each strand infecting certain parts of the body.
UQ's main commercialisation company, UniQuest licensed the vaccine technology to CSL in 1994.
The vaccine, predicted to become an international "blockbuster" drug, is expected to become one of the first Australian pharmaceutical successes to result in a fair share of economic flow back into the country.
Research Australia
The prescription-only vaccine is distributed in Australia and New Zealand by Melbourne based pharmaceutical manufacturer CSL and distributed worldwide by US drugmaker Merck & Co.
It sells for $465 for a three-dose shot but there are plans to have it considered for subsidy under the Pharmaceutical Benefits Scheme and eventually added to the national vaccination program for girls aged 12.
Professor Frazer, the immunologist named 2006 Australian of the Year for his team's work on the vaccine, is the Director of UQ's Centre for Immunology and Cancer Research.
Queensland Treasurer Anna Bligh announced a new Senior Smart State Fellowship at the vaccine launch in honour of Dr Zhou.
Ms Bligh said the three-year, $450,000 Jian Zhou Fellowship would be offered to a Queenslander to advance research and development in immunology and cancer research.
The State Government will contribute $100,000 a year for three years, matched by a $50,000-a-year commitment from CSL.
Professor Zhou's son Andreas, a 20-year-old industrial design student, said he was proud of his father's legacy.
"We're really happy that the vaccine has come through with 100 percent on the test trials but also really sad because my father can't be here with us today," Mr Zhou said.
"We're happy it's finally out there and people can start getting vaccinated."
Gardasil has been approved for use in girls and women aged nine to 26 in Australia and the US.
Cervical cancer kills about 270,000 women worldwide each year.
HPV causes abnormal cells or tissue growth on the feet, hands, vocal cords, mouth and genitals.
About 60 types of HPV have been identified so far with each strand infecting certain parts of the body.
UQ's main commercialisation company, UniQuest licensed the vaccine technology to CSL in 1994.
The vaccine, predicted to become an international "blockbuster" drug, is expected to become one of the first Australian pharmaceutical successes to result in a fair share of economic flow back into the country.
Research Australia
Cancer Vaccine Current Events and Cancer Vaccine News RSSCommon diabetes drug may 'revolutionize' cancer therapies
Researchers at McGill University and the University of Pennsylvania have discovered that a widely used anti-diabetic drug can boost the immune system and increase the potency of vaccines and cancer treatments.
Microparticle immune response modifier shows broad effects against recurrent or metastatic cancer
MIS416, a novel microparticle-based immune response modifier, demonstrated the ability to significantly reduce the number and size of metastatic tumors in preclinical mouse models of lung and breast cancers, Innate Therapeutics (formerly Virionyx Corporation) announced.
Goodbye needle, hello smoothie
Instead of a dreaded injection with a needle, someday getting vaccinated against disease may be as pleasant as drinking a yogurt smoothie.
Implants mimic infection to rally immune system against tumors
Bioengineers at Harvard University have shown that small plastic disks impregnated with tumor-specific antigens and implanted under the skin can reprogram the mammalian immune system to attack tumors.
Chronic inflammation can help nurture skin cancer, study shows
Inflammation, a frontline defense against infection or disease, can help nurture skin cancer, researchers have found.
Vaccine against HER2-positive breast cancer offers complete protection in lab
Researchers at Wayne State University have tested a breast cancer vaccine they say completely eliminated HER2-positive tumors in mice - even cancers resistant to current anti-HER2 therapy - without any toxicity.
Different type of colon cancer vaccine reduces disease spread, Jefferson scientists show
Taking advantage of the fact that the intestines have a separate immune system from the rest of the body, scientists at the Kimmel Cancer Center at Jefferson in Philadelphia have found a way to immunize mice against the development of metastatic disease.
Math could help cure leukemia
When kids complain that math homework won't help them in real life, a new answer might be that math could help cure cancer.
Vaccine/antibody therapy effective, milder side effects in melanoma and ovarian cancer
One of the shortcomings of a therapy that uses millions of identical antibodies to boost the immune system's attack on cancer cells is that many patients whose tumors recede in response to the treatment also experience serious inflammatory problems, such as severe diarrhea and rashes.
Resisting lung cancer recurrence
What if we could prevent cancer recurrence for years after surgery by giving simple recall injections every two or three years" This concept may no longer be a fantasy.
More Cancer Vaccine Current Events and Cancer Vaccine News Articles
 |
Cancer Vaccines and Tumor Immunity by Rimas Orentas (Author), James W. Hodge (Author), Bryon D. Johnson PhD (Author) Cancer Vaccines and Tumor Immunity offers a review of the basic scientific discoveries that have moved forward into clinical trials. Presented in the context of real-world human research and experimentation, these major scientific advances demonstrate how our understanding of immune activation, T-regulatory cells, and autoimmunity will impact cancer vaccine design. The authors also explain how vaccination in the context of bone marrow transplantation will open new avenues for clinical study in the future. |
 |
Using the Immune System to Treat Cancer |
 |
Teaching About Immunity Kit by American Educational Products This kit clearly displays the interrelated workings of the Immunity System. Attack an invading anigen with a phagocyte or monbyte. Produce macrophages. T-Cells, B-Cells, Plasma Cells, and antibodies. Clone T and B cells to produce Helper, Killer, Memory and Suppression cells. Demonstrate the operation of AIDS, Cancer, Vaccines, Allergies, Autoimmune reactions and more right on the board. Students can readily participate in the "hands on" activities. The Plastick pieces will not break, chip, tear, peel or wear out! Comes complete with a 30" X 40" Demonstration Board, mounting legs, and Teacher's Guide with detailed lesson plans plus reproducible student worksheets. |
 |
The HPV Vaccine Controversy: Sex, Cancer, God, and Politics: A Guide for Parents, Women, Men, and Teenagers by Shobha S Krishnan (Author) The Human Papilloma Virus, so-called HPV, is one of the most widespread sexually transmitted diseases in America, with more than 20 million infected now and more than 6 million new cases detected each year. It is estimated that at least 50 percent of all sexually active people will be infected during their lifetimes. And while the silent disease may cause no symptoms in most cases, two strains of HPV cause some 70 percent of all cervical cancer, which strikes more than 10,000 women in the United States alone each year. So it is with great fanfare than an HPV vaccine, tested around the world and approved by the US government in 2006, is being marketed. But controversy surrounds the vaccine, which is being recommended for girls as young as 9 and may be mandated by state governments. In... |
 |
The Virus and the Vaccine: Contaminated Vaccine, Deadly Cancers, and Government Neglect by Debbie Bookchin (Author), Jim Schumacher (Author) 'This well-researched, well-documented book unfurls a compelling scientific saga...written with the zing of a medical thriller.'-The atlanta Journal-Constitution A gripping medical detective story, this book raises major ques-tions about vaccine safety and regulation and shows how power, politics, and prejudice influence the health policy decisions that affect our lives. Jonas Salk's polio vaccine is regarded as a verit-able medical miracle, for it largely eradicated one of the most feared diseases of the twentieth century. But the story of the vaccine has a dark side that has never been fully told before. Between 1954 and 1963, some 98 million Americans received polio vaccinations contaminated with a carcinogenic monkey virus, known as SV40. The government downplayed the incident, and it... |
 |
Love, Kristen: One young woman's courageous battle against cancer (2009 Next Generation Indie Book Award Finalist) by Kirk Forbes (Author) Kristen Forbes had just opened a new, exciting chapter in her life... fresh out of college, a promising career and then advanced cancer. Her father and author of her story documents his daughter's uncommon bravery. She never lost her faith, her sense of humor or the will to fight. Both of them have become activists to share her story to help the world eradicate cancer. Kristen's own journal entries provided the framework to tell her story. Walk along with Kristen now and experience her final year and marvel at all the miracles that happened along the way. A portion of the proceeds for this book will go to cancer research. |
 |
Vaccines for the Prevention of Cervical Cancer (Oxford Oncology Library) by Peter L. Stern (Editor), Henry C. Kitchener (Editor) Cervical cancer is the second most common form of cancer found in women, and it is responsible for more than a quarter of a million deaths worldwide each year. With approximately 70% of cervical cancers now known to be caused by two types of the human pailloma virus (HPV), there is great interest surrounding the approval of the first preventative vaccines for clinical use. Despite this excitement, many questions remain about how the new vaccines should best be implemented and how cervical cnancer screening will change following vaccination. Part of the Oxford Oncology Library series, this practical handbook provides an overview of the role of HPV in the pathology of cervical cancer and its current screening and management, the principles of immune control of HPV infection in cervical... |
 |
Charlie Rose - The Charlie Rose Science Series, Episode 4 (April 18, 2007) The Fourth Episode in The Charlie Rose Science Series, an hour on the latest in the rapidly evolving field of cancer research. Charlie is joined by, Sir Paul Nurse (President of The Rockefeller University), Harold Varmus (President, Memorial Sloan-Kettering Cancer Center), David Nathan (President Emeritus, Dana-Farber Cancer Institute), Deb Schrag (Memorial Sloan-Kettering Cancer Center) and Martin Abeloff (Director, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins). The panel discusses advances in screenings and early detection and other methods of prevention like the HPV vaccine, the changes in accuracy of diagnoses, and cancer treatments such as targeted therapies. This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy... |
 |
Cancer Vaccines and Immunotherapy (Cambridge Cancer Series) by Peter L. Stern (Editor), Peter C. L. Beverley (Editor), Miles Carroll (Editor) Rapid progress in the definition of tumor antigens, and improved immunization methods, bring effective cancer vaccines within reach. In this wide-ranging survey, leading clinicians and scientists review therapeutic cancer vaccine strategies against a variety of diseases and molecular targets. Intended for an interdisciplinary readership, their contributions cover the rationale, development, and implementation of vaccines in human cancer treatment, with specific reference to cancer of the cervix, breast, colon, bladder, and prostate, and to melanoma and lymphoma. They review target identification, delivery vectors and clinical trial design. The book begins and ends with lucid overviews from the editors, that discuss the most recent developments. |
 |
Cancer Vaccines (Annals of the New York Academy of Sciences) by Ralph M. Steinman (Editor), Kenichiro Hasumi (Editor), Olivera J. Finn (Editor), Jacques Banchereau (Editor) With ten million persons afflicted each year, no one is entirely immune to cancer and its devastating effects on individuals and families. But recent advances in the development of cancer vaccines—either as therapeutic agents or as preventative measures—are hopeful indicators of progress in this field. This volume comprises invited chapters from world-renowned researchers and clinicians that shed light on recent steps forward in immunotherapeutic and preventive approaches for future cancer vaccines. NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit www.blackwellpublishing.com/nyas. ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place... |
| © 2009 BrightSurf.com |